Cancer-related deep venous thrombosis: clinical importance, treatment challenges, and management strategies.
about
Predictors of venous thromboembolism in patients with advanced common solid cancersSymptomatic and incidental venous thromboembolic disease are both associated with mortality in patients with prostate cancer.Asymptomatic deep vein thrombosis and superficial vein thrombosis in ambulatory cancer patients: impact on short-term survivalThromboembolism in cancer patients: pathogenesis and treatment.A post hoc analysis of dalteparin versus oral anticoagulant (VKA) therapy for the prevention of recurrent venous thromboembolism (rVTE) in patients with cancer and renal impairment.Cancer and thrombosis: implications of published guidelines for clinical practice.Venous Thromboembolism in Cancer: Frequently Asked Questions When Guidelines are Inconclusive.Retrospective comparison of low molecular weight heparin vs. warfarin vs. oral Xa inhibitors for the prevention of recurrent venous thromboembolism in oncology patients: The Re-CLOT study.Cancer-Associated Venous Thromboembolism.Non-vitamin K oral anticoagulants versus vitamin K antagonists in the treatment of venous thromboembolic disease.Venous thromboembolism prophylaxis in patients undergoing abdominal and pelvic cancer surgery: adherence and compliance to ACCP guidelines in DIONYS registry.Risk factors for venous thromboembolic events in cancer patients.Secondary prevention of venous thromboembolic events in patients with active cancer: enoxaparin alone versus initial enoxaparin followed by warfarin for a 180-day period.Expression of coagulation factors and their receptors in tumor tissue and coagulation factor upregulation in peripheral blood of patients with cerebral carcinoma metastases.The Role of Direct Oral Anticoagulants in Treatment of Cancer-Associated ThrombosisThe incidence and predictors of thromboembolic events in patients with lung cancer
P2860
Q33810510-6AFD8ED0-F16E-4886-BC0D-555B90DACEA9Q34050284-2988C5D7-C43D-46CA-92B1-76F7F051680CQ36387867-238CB893-6E53-49C1-92B4-B39DD4E4E03FQ36588644-888E9917-0F89-4744-9B7F-F9D0AA6E8A02Q37293267-4A6017DA-9BDC-4F67-BF9B-7885E7F1D1DFQ37533816-A1C5C7DF-632B-415E-B9A9-EB2BA7F50A0DQ38381351-65D3963D-01DA-479C-82B9-20C525AE32E1Q38676172-F4878E5B-9F86-468A-A972-5BBE43A63444Q38748038-94DA361A-722B-4AD4-807A-8C2C2406C58FQ38964210-C978D4C6-355B-42F5-87A0-034C067A51FBQ39367603-0508E09D-F526-46EA-92BF-473CA31AA9CEQ40494174-CFAC8342-4FFF-4F39-81D9-B13C540EC39FQ44988252-C507AFBF-7BCA-451E-A259-C7BDE6704A87Q53747238-1A03D6E6-503F-4923-A9AC-374EC2DA4CDAQ58776758-A832E1D8-CA1E-43B0-AC24-3938EF6D3862Q59074701-260B4EAC-BFBF-4145-8A91-EC473E387406
P2860
Cancer-related deep venous thrombosis: clinical importance, treatment challenges, and management strategies.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Cancer-related deep venous thr ...... es, and management strategies.
@ast
Cancer-related deep venous thr ...... es, and management strategies.
@en
type
label
Cancer-related deep venous thr ...... es, and management strategies.
@ast
Cancer-related deep venous thr ...... es, and management strategies.
@en
prefLabel
Cancer-related deep venous thr ...... es, and management strategies.
@ast
Cancer-related deep venous thr ...... es, and management strategies.
@en
P356
P1476
Cancer-related deep venous thr ...... es, and management strategies.
@en
P2093
Steven R Deitcher
P304
P356
10.1055/S-2003-40963
P577
2003-06-01T00:00:00Z